Wells Fargo & Co. Starts Stock Coverage on Advisory Board (ABCO)

Research analysts at Wells Fargo & Co. (NYSE: WFC) began coverage on shares of Advisory Board (NASDAQ: ABCO) in a report released on Tuesday. The firm set a “market perform” rating on the stock. The analysts noted that the move was a valuation call.

Advisory Board traded up 3.20% on Tuesday, hitting $97.64. Advisory Board has a 52-week low of $46.72 and a 52-week high of $92.32. The company has a market cap of $1.633 billion and a price-to-earnings ratio of 64.76.

Advisory Board last posted its quarterly earnings results on Wednesday, May 2nd. The company reported $0.62 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.47 by $0.15. Advisory Board’s revenue was up 32.9% compared to the same quarter last year. Analysts expect that Advisory Board will post $0.46 EPS next quarter.

Other equities research analysts have also recently issued reports about the stock. Analysts at Northland Securities initiated coverage on shares of Advisory Board in a research note to investors on Tuesday, May 8th. They set a “market perform” rating and a $100.00 price target on the stock. Analysts at Stifel Nicolaus raised their price target on shares of Advisory Board to $96.00 in a research note to investors on Friday, March 23rd.

The Advisory Board Company provides research and analysis, business intelligence and software tools, and installation support and management and advisory services to the health care and education industries.

Latest News

Google Spends $1 Billion To Purchase Waze
Google Spends $1 Billion To Purchase Waze
Apple Exploring Options In Net Radio
Apple Exploring Options In Net Radio
Taxpayers Pay Millions for Fed Workers Student Loan Relief
Taxpayers Pay Millions for Fed Workers Student Loan Relief
Aaron Hernandez, New England Patriots Player has House Searched
Aaron Hernandez, New England Patriots Player has House Searched
Supreme Court Allows Regulators to Challenge Generic Drug Agreements
Supreme Court Allows Regulators to Challenge Generic Drug Agreements
Car Sales in Europe Hit Record Lows
Car Sales in Europe Hit Record Lows


Leave a Reply

 
© 2010-2013 Zolmax.com, LLC.
Subscribe Subscribe